Table 1.
MODEL | SPECIES | DRUG | DOSE (mg/kg) | STUDY PROTOCOL | SEIZURE OUTCOME MEASURE | REFERENCE |
---|---|---|---|---|---|---|
PTZ | Zebrafish | CIT, REB, BUP | 10–300 μM | 1 min before sz induction | Seizure threshold | Vermoesen et al. (2011) |
PTZ | Mouse | REB, BUP | 5–10; 10–40 | 30 min before sz induction | Seizure threshold | Vermoesen et al. (2011) |
PTZ | Mouse | FLX | 20 | 60 min before sz induction | Survival | Kecskemeti et al. (2005) |
PTZ | Mouse | FLX | 1–20 | 30 min before sz induction | Seizure threshold, latency | Ugale et al. (2004) |
PTZ | Mouse | FLX | 10, 15 | 30 min before sz induction | Seizure threshold, susceptibility | Borowicz et al. (2012) |
PTZ | Mouse | HBK-14 | 20 | 30 min before sz induction | Seizure threshold | Pytka et al. (2017) |
PTZ | Mouse | SRT | 10 | Drug for 14 days before sz induction | Seizure threshold | Heydari and Davoudi (2017) |
PTZ | Rat | TNP | 20–80 | 30 min before sz induction | Seizure latency, frequency, severity | Reeta et al. (2016) |
PTZ | Mouse | SR 57227 | 1–10 | 30 min before sz induction | Seizure latency, severity, mortality | Li et al. (2014) |
PTZ | Mouse | TNP | 2.5–80 | 30 min before sz induction | Seizure onset | Uzbay et al. (2007) |
PTZ | Rat | VEN | 25–50 | 30 min before sz induction | Seizure severity and latency | Santos et al. (2002) |
PTZ | Mouse | mCPBG, CIT | 1–10; 0.1–50 | 30 min before sz induction | Seizure threshold | Payandemehr et al. (2012) |
PTZ | Mouse | APZ | 0.5–8 | 30, 60, 120 min before sz induction | Seizure latency | Shafaroodi et al. (2015) |
PTZ/DBA/2 | Mouse | 5-HT | 800 μg | Intracranial injection 10 min before sz induction | Seizure severity | Schlesinger et al. (1969) |
PTZ | Mouse | REB | 4–15 | 30 min before sz induction | Seizure threshold | Poplawska et al. (2015) |
PTZ (kindling) | Mouse | FLV | 5–20 | 30 min before sz induction | Seizure severity, brain dmg | Alhaj et al. (2015) |
Pilocarpine | Zebrafish | CIT | 10–300 μM | 1 min before sz induction | Seizure threshold | Vermoesen et al. (2011) |
Pilocarpine | Rat | FLX | 20 | Drug for 5 days after sz induction | Seizure frequency | Hernandez et al. (2002) |
Pilocarpine | Rat | FLX | 20 | Drug for 10 days once epileptic | Seizure threshold | Mazarati et al. (2008) |
Pilocarpine | Rat | PAR | 5 | Drug for 4 days after sz induction | Seizure frequency, severity, brain dmg | Lin et al. (2017) |
KA | Mouse | CIT | 10 | Drug for 7 days before sz induction | Seizure severity | Jaako et al. (2011) |
KA | Rat | BUP | 10, 50 | 30 min before sz induction | Seizure latency, severity, brain dmg | Lin et al. (2013) |
KA | Rat | CIT, REB | 15, 20–30 | Drug for 4 days once epileptic | Seizure frequency, duration | Vermoesen et al. (2012) |
MES | Mouse | APZ | 1–2 | 60 min before sz induction | Seizure mortality, tonic phase duration | Shafaroodi et al. (2015) |
MES | Mouse | BUP | 15–30 | 30 min before sz induction | Seizure threshold | Tutka et al. (2004) |
MES | Mouse | REB, FLX, CIT, DLX | 0.1–30; 10; 20; 10 | 30 min before sz induction | Seizure mortality | Kruse et al. (2019) |
MES | Mouse | VEN | 12.5, 25 | 30 min before sz induction | Seizure threshold | Borowicz et al. (2011) |
MES | Mouse | VEN | 12.5, 25 | Drug for 14 days before sz induction | Seizure threshold | Borowicz et al. (2011) |
MES | Mouse | FLX | 2.5, 5, 10 | 30 min before sz induction | AED ED50 | Leander (1992) |
MES | Rat | FLX, FEN | 10, 15 | 60 min before sz induction | Hind limb extension | Buterbaugh (1978) |
MES | Mouse | DOI, CIT, TCB-2, MK-212 | 0.3, 1; 20; 10; 10 | 30 min before sz induction | Seizure mortality | Buchanan et al. (2014) |
MES | Mouse | HBK-14, HBK-15 | 20 | 30 min before sz induction | Seizure threshold | Pytka et al. (2017) |
MES | Mouse | FLX | 10 | 60 min before sz induction | Seizure threshold | Raju et al. (1999) |
MES/PTZ | Mouse/Rat | 5-HTP | 100 | 30 min before sz induction | Seizure threshold | Killian and Frey (1973) |
MES | Mouse | REB | 8–16 | 30 min before sz induction | Seizure threshold | Borowicz et al. (2014) |
6 Hz Corneal Stimulation | Mouse | HBK-14, HBK-15 | 20 | 30 min before sz induction | Seizure threshold | Pytka et al. (2017) |
Ear shock | Mouse | FLX | 15–25 | 30 min before sz induction | Seizure threshold | Borowicz et al. (2006) |
Hippocampal kindling | Rat | FLX | 10 nmol | 15 min before sz induction | Electrical threshold | Wada et al. (1993) |
Hippocampal kindling | Rat | 5-HTP | 50 | 60 min before sz induction | Electrical threshold | Cavalheiro et al. (1981) |
Hippocampal kindling | Rat | FLX | 10 | Drug for 21 days before sz induction | Electrical threshold | Wada et al. (1995) |
Amygdala kindling | Cat | FLX | 2–10 | 1–49 hr before seizure induction | Electrical threshold | Siegal and Murphy (1979) |
Amygdala kindling | Mouse | FLX | 10 | Osmotic mini pump, 30 day administration | Afterdischarge threshold | Li et al. (2018) |
GEPR-3 and GEPR-9 | Rat | FLX | 30 | 1–5 hr before seizure induction | Seizure severity | Dailey et al. (1992) |
GEPR-3 and GEPR-9 | Rat | FLX | 7–20 | Sz induced every 7 days for 28 days | Seizure threshold | Dailey et al. (1992) |
GEPR-9 | Rat | FLX | 15 | 60 min before sz induction | Severity and latency | Yan et al. (1994) |
El mice | Mouse | CIT | 0.01, 0.02, 0.04 | Drug for 14 days before sz induction | Seizure threshold | Kabuto et al. (1994) |
El mice | Mouse | FLX | 10 | Drug for 3 or 7 days before sz induction | Seizure threshold | Richman and Heinrichs (2007) |
DBA/1 and PTZ | Mouse | 5-HTP | 100–150 | Drug for 2 days before sz induction | S-IRA, seizure incidence | Zhang et al. (2015) |
DBA/1 | Mouse | FLX | 30 | 30 min before sz induction | S-IRA | Zeng et al. (2015) |
DBA/1 | Mouse | SRT | 40–75 | 30 min before sz induction | S-IRA, seizure incidence | Faingold and Randall (2013) |
DBA/1 | Mouse | FEN | 10–40 | 30 min, 12 hr, 24 hr, or 72 hr before sz induction | Seizure severity, ED50, S-IRA | Tupal and Faingold (2019) |
DBA/2 | Mouse | FLX | 15–25 | 30 min or 72 hr before sz induction | S-IRA, seizure incidence | Tupal and Faingold (2006) |
DBA/1 | Mouse | SR 57227, FLX | 20–40; 40 | 30 min before sz induction | S-IRA, seizure incidence | Faingold et al. (2016) |
DBA/1 | Mouse | FLX | 15–70 acute, 20 chronic | 30 min before or for 5 days before sz induction | S-IRA, seizure incidence | Faingold et al. (2011) |
DBA/1 | Mouse | FLV, PAR,VEN | 50–80; 75–100; 25–100 | 30, 60, 120 min prior to sz induction | S-IRA, seizure incidence | Faingold et al. (2014) |
Audiogenic Sz | Rat | FLX | 25 | 60 min before sz induction | Seizure severity | Ismaylova and Madzhidi (2012) |
Audiogenic Sz | Rat | FLX | 20 | Drug for 14 days before sz induction | Seizure severity | Sarkissova et al. (2016) |
WAG/Rij Absence Sz | Rat | FLX, DLX | 30; 10–30 | Drug administration for 7 weeks | Seizure and immobility duration | Citraro et al. (2015) |
Flurothyl | Mouse | REB | 20 | Drug for 21 days before sz induction | Seizure latency | Ahern et al. (2006) |
Focal pilocarpine | Rat | CIT | 1 μM | 4 hr intracranial infusion before sz induction | Seizure severity | Clinckers et al. (2004) |
Focal bicuculline | Rat | FLX | 5–20 | 60 min before sz induction | Seizure frequency, severity | Prendiville and Gale (1993) |
Focal bicuculline | Rat | FLX | 1.75–7 nM | 15 min before sz induction | Seizure threshold | Pasini et al. (1992) |
Picrotoxin | Mouse | FLX | 20 | 65 min before sz induction | Seizure latency | Pericic et al. (2005) |
Picrotoxin | Mouse | FLX | 20 | Drug for 5 days before sz induction | Seizure latency | Pericic et al. (2005) |
4-AP | Rat | FLX | 10 | Drug for 7 days before sz induction | Seizure latency, brain dmg | Shiha et al. (2017) |
4-AP | Rat | SRT | 2.5, 25 | 4 hr before sz induction | Seizure frequency, EEG changes | Sitges et al. (2012) |
4-AP | Rat | SRT | 0.75 | Drug for 7 days before sz induction | Seizure frequency, EEG changes | Sitges et al. (2012) |
4-AP | Rat | SRT | 0.75, 2.5 | 4 hr before sz induction | Seizure suppression | Sitges et al. (2016) |
BUP, bupropion; CIT, citalopram; FEN, fenfluramine; FLV, fluvoxamine; FLX, fluoxetine; GEPR, genetically epilepsy prone rats; hr, hour; KA, kainic acid; MAP, maprotiline; min, minute; PAR, paroxetine; REB, reboxetine; SRT, sertraline; sz, seizure; VEN, venlafaxine; CLM, clemizole.